This manufacturer of medical, surgical, and diagnostic devices has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate has also remained unchanged over the same period. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
AngioDynamics currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Investors interested in the medical instruments industry may also consider stocks like ERBA Diagnostics, Inc. (ERB), Edwards Lifesciences Corp. (EW) and Alphatec Holdings, Inc. (ATEC). While ERBA Diagnostics sports a Zacks Rank #1, Edwards Lifesciences and Alphatec Holdings carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment